| Ellen Middendorf, MD | |
|
4600 Memorial Dr, Ste. 160, Belleville, IL 62226-5368 | |
| (618) 235-0460 | |
| (618) 235-1464 |
| Full Name | Ellen Middendorf |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 4600 Memorial Dr, Belleville, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245234988 | NPI | - | NPPES |
| 036108143 | Medicaid | IL | |
| 1245234988 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036-108143 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Middendorf, MD 4600 Memorial Dr, Ste. 160, Belleville, IL 62226-5368 Ph: (618) 235-0460 | Ellen Middendorf, MD 4600 Memorial Dr, Ste. 160, Belleville, IL 62226-5368 Ph: (618) 235-0460 |
News Archive
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.
Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.
Researchers in the University of Leicester's Department of Cell Physiology and Pharmacology have identified a cellular mechanism that could underlie the development of tinnitus following exposure to loud noises. The discovery could lead to novel tinnitus treatments, and investigations into potential drugs to prevent tinnitus are currently underway.
UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.
› Verified 1 days ago
Wallace K Abel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 311 W Lincoln St Ste 200, Belleville, IL 62220 Phone: 618-234-2566 Fax: 618-234-5650 | |
Dr. Shannon Erin Witty, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 S 3rd St Ste 400, Belleville, IL 62220 Phone: 618-233-7880 | |
Dr. Victoria Oluwaseun Spencer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-6220 Fax: 618-257-6679 | |
Naveen Kumar Reddy Bondalapati, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-233-3066 Fax: 618-257-6679 | |
David J Nyquist, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-6220 Fax: 618-257-6679 | |
Niraj J Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4700 Memorial Dr Ste 210, Belleville, IL 62226 Phone: 618-767-7000 | |
Brett Allen Nance, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 S 3rd St, Suite 400, Belleville, IL 62220 Phone: 618-233-7880 Fax: 618-222-4792 |